<DOC>
	<DOC>NCT01704950</DOC>
	<brief_summary>The aim of this study is to provide data and the guidelines for the use of IDRT SL in small wounds, acute and chronic (less than 6 months), showing the benefits and the easy to use of this product as a one stage procedure.</brief_summary>
	<brief_title>Clinical Outcome of Defect Reconstruction Using IDRT Single Layer : Results From a Prospective Multicentric Trial</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<criteria>Age ≥ 18 years Patient with 1 traumatic wound (burns included) or 1 reconstruction wound (oncological wounds included) Patients for whom the surgeon has recommended that an INTEGRA® SL matrix be implanted (even if the patient is not taking part in the study) with a Split Thickness Skin Graft in the same operating procedure Wound treated with only one layer of a maximum size 10cm*12.5cm Immunosuppressed patient Chronic wound (with no healing since 6 months) Addition of any substances (growth factor, stem cells,…) in the IDRT SL during the surgery Patient with a corticoid treatment with a daily dose greater than 5 mg Patients whose life expectancy is less than 12 months Patients whose mental health or health condition (Visual deficiency, Alzheimers…) would compromise completion of the selfevaluation questionnaires Patient with an hypersensitivity to bovine collagen, chondroitin Patient with clinical signs of infection (fever, pain, colour, swelling,…) and for whom the investigator diagnosed infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>